Sunday, September 13, 2026

Markets & Technology

2 articles

Global Chip Rally Leaves Software Behind as Investors Bet on AI Hardware

Global Chip Rally Leaves Software Behind as Investors Bet on AI Hardware

Micron and Dell each surged 5% on June 25 as investors rotated out of AI software into semiconductor and HPC hardware worldwide. Intel gained 3.8%, SanDisk 4%, while enterprise software stocks fell — a divergence playing out across U.S., Asian, and European markets. The shift signals a global repricing of where AI value is created: in silicon and servers, not applications.

LM Salvado
Intel +240%, AMD +112%: Global AI Inference Shift Leaves Nvidia Behind in 2026 Rally

Intel +240%, AMD +112%: Global AI Inference Shift Leaves Nvidia Behind in 2026 Rally

Intel has surged 240% year-to-date in 2026 while Nvidia — the world's dominant AI chipmaker — has returned just 15%. The divergence reflects how global AI infrastructure spending is flowing beyond training GPUs into inference-optimised hardware. Markets from Wall Street to Tokyo are repricing chipmakers at the edges of Nvidia's ecosystem.

LM Salvado
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com